Ona Therapeutics Completes $86.6 Million Series B Financing

Source Summary

Wilson Sonsini Goodrich & Rosati has advised Ona Therapeutics. Ona Therapeutics, a biopharmaceutical company focused on pioneering antibody-drug conjugates (ADCs) for treatment-resistant cancers, has announced the [...]